Julia Madsen - 03 Jun 2025 Form 4 Insider Report for STERIS plc (STE)

Role
Sr. VP and GM, Life Sciences
Signature
/s/ John P. Ubbing, Authorized Representative under Power of Attorney
Issuer symbol
STE
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 16:38:49 UTC
Previous filing
04 Jun 2025
Next filing
06 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Madsen Julia Sr. VP and GM, Life Sciences 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND /s/ John P. Ubbing, Authorized Representative under Power of Attorney 05 Jun 2025 0001819129

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Award $0 +1,998 +22% $0.000000 10,956 03 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Award $0 +7,100 $0.000000 7,100 03 Jun 2025 Ordinary Shares 7,100 $267.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 3, 2025, 4,689 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028.
F2 This option becomes exercisable as follows: 1,775 on June 3, 2026, 1,775 on June 3, 2027, 1,775 on June 5, 2028 and 1,775 on June 4, 2029.